Literature DB >> 23381316

The poorly explored impact of uncontrolled asthma.

Paul M O'Byrne1, Søren Pedersen2, Michael Schatz3, Anders Thoren4, Ella Ekholm4, Lars-Göran Carlsson4, William W Busse5.   

Abstract

The goal of asthma management is to achieve disease control; however, despite the availability of effective and safe medications, for many patients asthma remains uncontrolled. One reason for this is the fear of long-term side effects from the regular use of inhaled corticosteroids (ICSs). Adverse effects of poorly controlled asthma (for example, obesity, pneumonia, and risks to the fetus) can be perceived as side effects of ICSs. Poorly controlled asthma adversely affects children's cardiovascular fitness, while children with well-controlled asthma perform at the same level as their peers. Children with uncontrolled asthma also have a higher frequency of obesity than children with controlled asthma. Stress can affect asthma control, and children with poorly controlled asthma are more likely to have learning disabilities compared with those with good control. In adults, focused attention and concentration are negatively affected in patients with untreated asthma, and patients with asthma are at greater risk for depression. Also, poorly controlled asthma increases the risks of severe asthma exacerbations following upper respiratory and pneumococcal pulmonary infections. ICSs used to improve asthma control have been demonstrated to improve all of these outcomes. Lastly, the risks of uncontrolled asthma during pregnancy are substantially greater than the risks of recommended asthma medications. Treatments to maintain asthma control are the best approach to optimize maternal and fetal health in the pregnancies of women with asthma. The maintenance of asthma control has significant advantages to patients and greatly outweighs the potential risks of treatment side effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23381316     DOI: 10.1378/chest.12-0412

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  27 in total

Review 1.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

2.  Genetic variation in uncontrolled childhood asthma despite ICS treatment.

Authors:  M Leusink; S J H Vijverberg; L Koenderman; J A M Raaijmakers; J C de Jongste; P J Sterk; E J Duiverman; N C Onland-Moret; D S Postma; A de Boer; P I W de Bakker; G H Koppelman; A H Maitland-van der Zee
Journal:  Pharmacogenomics J       Date:  2015-05-12       Impact factor: 3.550

Review 3.  Severe Pediatric Asthma Therapy: Mepolizumab.

Authors:  Nicola Ullmann; Francesca Peri; Olivia Florio; Federica Porcaro; Elisa Profeti; Alessandro Onofri; Renato Cutrera
Journal:  Front Pediatr       Date:  2022-07-01       Impact factor: 3.569

4.  A Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma.

Authors:  Andrew Menzies-Gow; David J Jackson; Mona Al-Ahmad; Eugene R Bleecker; Francisco de Borja G Cosio Piqueras; Stephen Brunton; Giorgio Walter Canonica; Charles K N Chan; John Haughney; Steve Holmes; Janwillem Kocks; Tonya Winders
Journal:  Adv Ther       Date:  2022-10-17       Impact factor: 4.070

5.  Individual and Neighborhood Factors Associated with Undiagnosed Asthma in a Large Cohort of Urban Adolescents.

Authors:  Jean-Marie Bruzzese; Sharon Kingston; Katherine A Falletta; Emilie Bruzelius; Lusine Poghosyan
Journal:  J Urban Health       Date:  2019-04       Impact factor: 3.671

6.  Improving Care of Inner-City Children with Poorly Controlled Asthma: What Mothers Want You to Know.

Authors:  Melissa H Bellin; Angelica Newsome; Cassie Lewis-Land; Joan Kub; Shawna S Mudd; Rachel Margolis; Arlene M Butz
Journal:  J Pediatr Health Care       Date:  2018-03-12       Impact factor: 1.812

7.  Pneumococcal Vaccination Among Adults With Work-related Asthma.

Authors:  Katelynn E Dodd; Jacek M Mazurek
Journal:  Am J Prev Med       Date:  2017-09-27       Impact factor: 5.043

Review 8.  A summary of the new GINA strategy: a roadmap to asthma control.

Authors:  Helen K Reddel; Eric D Bateman; Allan Becker; Louis-Philippe Boulet; Alvaro A Cruz; Jeffrey M Drazen; Tari Haahtela; Suzanne S Hurd; Hiromasa Inoue; Johan C de Jongste; Robert F Lemanske; Mark L Levy; Paul M O'Byrne; Pierluigi Paggiaro; Soren E Pedersen; Emilio Pizzichini; Manuel Soto-Quiroz; Stanley J Szefler; Gary W K Wong; J Mark FitzGerald
Journal:  Eur Respir J       Date:  2015-07-23       Impact factor: 16.671

Review 9.  The GINA asthma strategy report: what's new for primary care?

Authors:  Helen K Reddel; Mark L Levy
Journal:  NPJ Prim Care Respir Med       Date:  2015-07-30       Impact factor: 2.871

10.  Determinants of uncontrolled asthma in a Swedish asthma population: cross-sectional observational study.

Authors:  Mary Kämpe; Karin Lisspers; Björn Ställberg; Josefin Sundh; Scott Montgomery; Christer Janson
Journal:  Eur Clin Respir J       Date:  2014-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.